Immunopharmacology and Immunotoxicology

Immunopharmacology and Immunotoxicology  
Abbreviated title (ISO 4)
Immunopharm. Immunot.
Discipline Immunology, pharmacology, toxicology
Language English
Edited by Anders Elm Pedersen
Publication details
Publisher
Publication history
1978-present
Frequency 6/year
1.203
Indexing
ISSN 0892-3973 (print)
1532-2513 (web)
Links

Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies (e.g. acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation, and primary and secondary immunodeficiencies). It is published by Informa.

Editor-in-Chief

The Editor-in-Chief of Immunopharmacology and Immunotoxicology is Anders Elm Pedersen, University of Copenhagen, Danmark.[1][2]

Impact factor

According to the Journal Citation Reports it received in 2014 an impact factor of 1.203, ranking it 133rd out of 148 journals in the category "Immunology",[3] ranking it 204th out of 254 journals in the category "Pharmacology & Pharmacy"[4] and ranking it 73rd out of 87 journals in the category "Toxicology".[5]

References

  1. "Editorial Board". informapharmascience.com. Retrieved 2013-04-04.
  2. Website of Anders Elm Pedersen at University of Copenhagen, accessed at April, 4th, 2013
  3. "Journals Ranked by Impact: Immunology". 2014 Journal Citation Reports. Web of Science (Sciences ed.) (Thomson Reuters). 2015.
  4. "Journals Ranked by Impact: Pharmacology & Pharmacy". 2014 Journal Citation Reports. Web of Science (Sciences ed.) (Thomson Reuters). 2015.
  5. "Journals Ranked by Impact: Toxicology". 2014 Journal Citation Reports. Web of Science (Sciences ed.) (Thomson Reuters). 2015.

External links

This article is issued from Wikipedia - version of the Monday, July 13, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.